DK0666929T3 - Fremgangsmåde til inhibering af hyperproliferative cellers replikation - Google Patents

Fremgangsmåde til inhibering af hyperproliferative cellers replikation

Info

Publication number
DK0666929T3
DK0666929T3 DK93924312T DK93924312T DK0666929T3 DK 0666929 T3 DK0666929 T3 DK 0666929T3 DK 93924312 T DK93924312 T DK 93924312T DK 93924312 T DK93924312 T DK 93924312T DK 0666929 T3 DK0666929 T3 DK 0666929T3
Authority
DK
Denmark
Prior art keywords
hyperproliferative cells
hyperproliferative
polypeptide
relates
replication
Prior art date
Application number
DK93924312T
Other languages
English (en)
Inventor
Steven M Frisch
Original Assignee
Jolla Cancer Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Cancer Res Found filed Critical Jolla Cancer Res Found
Application granted granted Critical
Publication of DK0666929T3 publication Critical patent/DK0666929T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK93924312T 1992-10-13 1993-10-13 Fremgangsmåde til inhibering af hyperproliferative cellers replikation DK0666929T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/960,112 US5516631A (en) 1992-10-13 1992-10-13 Method of inhibiting replication of hyperproliferative cells
PCT/US1993/009774 WO1994009160A1 (en) 1992-10-13 1993-10-13 Method of inhibiting replication of hyperproliferative cells

Publications (1)

Publication Number Publication Date
DK0666929T3 true DK0666929T3 (da) 2003-09-15

Family

ID=25502805

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93924312T DK0666929T3 (da) 1992-10-13 1993-10-13 Fremgangsmåde til inhibering af hyperproliferative cellers replikation

Country Status (10)

Country Link
US (2) US5516631A (da)
EP (1) EP0666929B1 (da)
JP (1) JP3492364B2 (da)
AT (1) ATE240404T1 (da)
CA (1) CA2147127A1 (da)
DE (1) DE69332978T2 (da)
DK (1) DK0666929T3 (da)
ES (1) ES2194849T3 (da)
PT (1) PT666929E (da)
WO (1) WO1994009160A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643567A (en) * 1990-12-04 1997-07-01 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
JPH06296489A (ja) * 1992-11-20 1994-10-25 Univ Texas Syst 網膜芽腫−関連タンパク質をコードする細胞性遺伝子
US5776743A (en) 1994-09-06 1998-07-07 La Jolla Cancer Research Foundation Method of sensitizing tumor cells with adenovirus E1A
US6326356B1 (en) 1996-10-18 2001-12-04 Board Of Regents, The University Of Texas System Suppression of neu overexpression using a mini-E1A gene
US5869040A (en) * 1995-06-07 1999-02-09 Biogen, Inc Gene therapy methods and compositions
US5763415A (en) 1995-08-03 1998-06-09 John Hopkins University School Of Medicine Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
WO1997005898A1 (en) * 1995-08-03 1997-02-20 The Johns Hopkins University School Of Medicine Delivery of an agent to the ductal epithelium in the prophylactic and therapeutic treatment of cancer
IL137164A0 (en) 1998-01-23 2001-07-24 Newbiotics Inc Enzyme catalyzed therapeutic agents
US7462605B2 (en) * 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
US6413974B1 (en) * 1998-02-26 2002-07-02 Aventis Pharmaceuticals Inc. 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
US6479487B1 (en) * 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
US6683061B1 (en) * 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
BR0012676A (pt) 1999-07-22 2003-07-01 Newbiotics Inc Métodos para tratamento de tumores resistentes a terapia
US20040266834A1 (en) * 1999-10-14 2004-12-30 Copland John A. Thiazolidinediones alone or in cabination with other therapeutic agents for cancer therapy
IL149404A0 (en) * 2002-04-29 2002-11-10 Yissum Res Dev Co METHODS AND COMPOSITIONS FOR MODULATING β-CATENIN PHOSPHORYLATION
US20040191761A1 (en) * 2003-03-27 2004-09-30 Routes John M. Modified adenoviral E1A constructs and methods of use thereof
ES2385251B1 (es) 2009-05-06 2013-05-06 Fundació Privada Institut D'investigació Biomèdica De Bellvitge Adenovirus oncolíticos para el tratamiento del cáncer.
WO2012071492A1 (en) 2010-11-23 2012-05-31 Georgia Tech Research Corporation Mir-200 family induces mesenchymal-to-epithelial transition (met) in ovarian cancer cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643567A (en) * 1990-12-04 1997-07-01 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
ES2093248T3 (es) * 1990-12-04 1996-12-16 Univ Texas Metodos y composiciones para la supresion de la transformacion mediada por el neu.
US5641484A (en) * 1990-12-04 1997-06-24 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
DK0931830T3 (da) * 1993-02-16 2001-06-11 Onyx Pharma Inc Cytopatiske vira til terapi og profylakse af neoplasi

Also Published As

Publication number Publication date
ATE240404T1 (de) 2003-05-15
WO1994009160A1 (en) 1994-04-28
EP0666929A1 (en) 1995-08-16
ES2194849T3 (es) 2003-12-01
DE69332978T2 (de) 2004-02-26
PT666929E (pt) 2003-08-29
CA2147127A1 (en) 1994-04-28
EP0666929B1 (en) 2003-05-14
US5516631A (en) 1996-05-14
EP0666929A4 (en) 1996-07-10
US5866550A (en) 1999-02-02
JPH08504573A (ja) 1996-05-21
JP3492364B2 (ja) 2004-02-03
DE69332978D1 (de) 2003-06-18

Similar Documents

Publication Publication Date Title
DK0666929T3 (da) Fremgangsmåde til inhibering af hyperproliferative cellers replikation
IE820069L (en) Recombinant dna encoding a polypeptide
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
ES8800359A1 (es) Metodo de produccion de factor viii:c humano
HUP9900050A1 (hu) Rekombináns adenovírusok, és felhasználásuk adeno-asszociált vírusok (AAV) előállítására, komplementáló sejtvonalak, és az illető adenovírusokat tartalmazó gyógyszerkészítmények
ATE198621T1 (de) Herstellung und verwendung von transgenen mäusen mit fehlender expression von cd28
DK240088D0 (da) Fremgangsmaade til transformation af et plantecellematerale
ES544868A0 (es) Procedimiento de obtencion de una proteina de factor estimu-lante de colonias (csf) en primates
AU3752795A (en) Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
DK62881A (da) Rekombinant-dna indeholdende et analysekodningsgen, genetisk konstruerede mikroorganismer med evne til massiv produktion af amylolytiske enzymer og fremgangsmaade til fremstilling af saadanne enzymer
DE69723855D1 (de) Verfahren zur herstellung von polypeptiden in surfaktinmutanten von bacillus zellen
AU7659298A (en) Recombinant lactoferrin, methods of production from plants and uses
EP0182448A3 (en) Production of factor viii and related products
DK432987D0 (da) Fremgangsmaade til forbedring af ekspressionen af eukaryotprotein
DK358787D0 (da) Vaekstfaktor, nucleotidsekvens kodende for vaekstfaktoren ekspressionsplasmid omfattende nucleotidsekvensen,vaert indeholdende plasmidet protein fremstillet af vaerten, fremgangsmaade til fremstilling af vaekstfaktoren og farmaceutisk praeparat indeholdendevaekstfaktoren
DK619284D0 (da) Udtrykkelsesplasmid til forbedret produktion af heterologt protein ibakterier og fremgangsmaade til fremstilling af dette protein samtfremgangsmaade til fremstilling af plasmidet
AU7526881A (en) Method of plant tissue + cell culture
IL129139A0 (en) Vertebrate smoothened proteins
EP2298911A3 (en) Methods for producing polypeptides in respiratory-deficient cells
DK0658626T3 (da) Fremgangsmåder til produktion af protein C
HK1028789A1 (en) High level of expression of ingap.
ATE322540T1 (de) Zubereitung für übertragung der aktive tumorspezifische immunisierung von einem immunisiertem allogenem knochenmarkspender
EP0163243A3 (en) Improved human t or b cell lines and a process for producing immunologically active substances using the same
SE8901715L (sv) En plasmid dna-konstruktion innehaallande dna-sekvenser
KR850001803A (ko) 펩티드(peptide)의 제조방법